For Mr Hur, capturing the American market is a priority because it would mean Paris Baguette has succeeded internationally.
But Serbia's president, Aleksandar Vucic, is unapologetic. "It's important to overcome the burden from 1999," he tells the BBC."We are ready to build better relations with the US – I think that is terribly important for this country."
That view garners a degree of sympathy from Belgrade's international business community.Foreign direct investment inflows have more than tripled over the past decade. But GDP per capita remains low compared to EU member states. It stands at just one third of the bloc's average.To keep those figures moving in the right direction, attracting new investors is vital. And while the financial details of the Ministry of Defence development have not been revealed, the New York Times has reported that the Serbian government will
"For a small and specific market – ex-Yugoslavia, outside the EU – all publicity is good publicity," says James Thornley, a former senior partner at KPMG Serbia, who is now a partner at financial consultants KP Advisory in Belgrade."If you have major international players coming in, it's a pull, it's a draw. You're getting the name and opportunity out there."
Mr Thornley has lived in Serbia for 25 years and is fully aware of the sensitivities surrounding the Defence Ministry complex. But he believes that views would change once people saw the benefits of the development.
"That site is an eyesore and should be resolved," he says. "Nothing's happened for 26 years, let's get it sorted out."India, home to 27% of the world's tuberculosis cases, sees two TB-related deaths every three minutes. India's TB burden has long been tied to poor case detection, underfunding and erratic drug supply.
Despite this grim reality, the country has set an ambitious goal. It aims to eliminate TB by the end of 2025, five years ahead of the global target set by the World Health Organization (WHO) and United Nations member states.Elimination, as defined by the WHO, means cutting new TB cases by 80% and deaths by 90% compared with 2015 levels.
But visits to TB centres in Delhi and the eastern state of Odisha revealed troubling gaps in the government's TB programme.In Odisha's Khordha district, around 30km (18.6 miles) from state capital Bhubaneshwar, 32-year-old day-labourer Kanhucharan Sahu is struggling to continue his two-year-old daughter's TB treatment, with government medicines unavailable for three months and private ones costing 1,500 rupees a month - an unbearable burden.